Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth M Carpenter

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Substance Abuse Treatment|February 25, 2014
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Journal of Consulting and Clinical Psychology|May 9, 2012
"Old dogs" and new skills: how clinician characteristics relate to motivational interviewing skills before, during, and after trainingKenneth M Carpenter, Wendy Y Cheng, Jennifer L Smith, et al.
The American Journal on Addictions|May 16, 2009
Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependenceWilfrid Noel Raby, Kenneth M Carpenter, Jami Rothenberg, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|March 18, 2009
Betting on change: modeling transitional probabilities to guide therapy development for opioid dependenceKenneth M Carpenter, Huiping Jiang, Maria A Sullivan, et al.
The American Journal of Psychiatry|August 29, 2020
Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRIClifford M Cassidy, Kenneth M Carpenter, Anna B Konova, et al.
Behavior Therapy|November 1, 2011
Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidanceFrank W Bond, Steven C Hayes, Ruth A Baer, et al.
Drug and Alcohol Dependence|January 4, 2015
Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneMaria A Sullivan, Adam Bisaga, Andrew Glass, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
The American Journal of Drug and Alcohol Abuse|March 17, 2007
Providing live supervision via teleconferencing improves acquisition of motivational interviewing skills after workshop attendanceJennifer L Smith, Paul C Amrhein, Adam C Brooks, et al.
Addiction (Abingdon, England)|January 10, 2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin, John Mariani, Daniel J Brooks, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Substance Abuse Treatment|February 25, 2014
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Journal of Consulting and Clinical Psychology|May 9, 2012
"Old dogs" and new skills: how clinician characteristics relate to motivational interviewing skills before, during, and after trainingKenneth M Carpenter, Wendy Y Cheng, Jennifer L Smith, et al.
The American Journal on Addictions|May 16, 2009
Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependenceWilfrid Noel Raby, Kenneth M Carpenter, Jami Rothenberg, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|March 18, 2009
Betting on change: modeling transitional probabilities to guide therapy development for opioid dependenceKenneth M Carpenter, Huiping Jiang, Maria A Sullivan, et al.
The American Journal of Psychiatry|August 29, 2020
Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRIClifford M Cassidy, Kenneth M Carpenter, Anna B Konova, et al.
Behavior Therapy|November 1, 2011
Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidanceFrank W Bond, Steven C Hayes, Ruth A Baer, et al.
Drug and Alcohol Dependence|January 4, 2015
Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneMaria A Sullivan, Adam Bisaga, Andrew Glass, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
The American Journal of Drug and Alcohol Abuse|March 17, 2007
Providing live supervision via teleconferencing improves acquisition of motivational interviewing skills after workshop attendanceJennifer L Smith, Paul C Amrhein, Adam C Brooks, et al.
Addiction (Abingdon, England)|January 10, 2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin, John Mariani, Daniel J Brooks, et al.
Pageof 5